Systematic review and trial sequential analysis of high-intensity focused ultrasound combined with chemotherapy versus chemotherapy in the treatment of unresectable pancreatic ductal adenocarcinoma.
Jing GuoYun-Bing WangJin-Yun ChenWensheng QiuWenzhi ChenPublished in: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group (2021)
Our analysis suggests that HIFU combined with chemotherapy intravenously will prolong survival for unresectable PDAC patients. The TSA showed that the survival benefit of combined therapy was definitive and there was no need to expand the sample size for repetitive exploration.
Keyphrases
- locally advanced
- high intensity
- systematic review
- rectal cancer
- squamous cell carcinoma
- radiation therapy
- resistance training
- end stage renal disease
- ejection fraction
- newly diagnosed
- clinical trial
- prognostic factors
- meta analyses
- stem cells
- phase iii
- phase ii
- chemotherapy induced
- combination therapy
- replacement therapy
- smoking cessation
- body composition
- cell therapy